Cardiology devices are medical devices intended to use for diagnosis, treatment and monitoring of cardiovascular system and diseases. Cardiology devices are generally segmented into Cardiac Monitoring and Cardiac Rhythm Management, Cardiac Surgery, Electrophysiology and Ablation Devices, and Interventional Cardiology and Peripheral Vascular devices. The market is posed to witness a high growth due to increasing aging population, increasing number of patient suffering from cardiac diseases, rising patient awareness levels, technological advancement and increasing demand for minimally invasive medical procedures. According to the World Health Organization, globally, the population of individuals aged 65 and above was 570 million in 2013 and this figure is estimated to reach 1.5 billion (16% of global population) by 2050. Owing to this, the incidence of cardiovascular diseases is expected to increase. For instance, in 2013, 42.2 million people (aged above 60 years) were estimated to have CVD; moreover, in the U.S., from the total number of deaths among people aged 75 years and above, 66% deaths were related to CVDs. Furthermore, CVD is the major cause of mortality worldwide, translating to around 30% of all deaths. According to World Health Organization (WHO) estimates, 17.3 million people across the globe died of CVD in 2008 and around 24 million are estimated to die by 2030.
Technological advancements in the cardiology devices segment is one of the key trend and growth factor. Bioabsorbable stents is also one of the emerging technology. Bioabsorable stents technology is expected to seize a significant market size in the coming years, as it is capable of reducing post-surgical risks associated with restenosis to a great extent. Similarly, Tohoku University, Japan in collaboration with Konica Minolta have created a magnetic sensor that works at room temperature and that’s capable of detecting the changes of magnetic field of a person’s heart. Magnetocardiography could be a common heart assessment modality with the use of this sensor in the future.
There is growing need for compact devices. Ambulatory ECG monitoring is becoming increasingly important in both home care and clinical settings to detect symptomatic signs in patients with uncommon events. Holter monitors being used for ECG monitoring limit patient mobility owing to the size of the instruments. Hence, there is a growing need for compact devices that do not restrict patient mobility while simultaneously providing data.
The Cardiac Monitoring devices segment is categorized into electrocardiogram (ECG) devices, event monitors, implantable loop recorders (ILR), and cardiac output monitoring (COM) devices. The CRM devices segment is categorized into defibrillators, pacemakers, and cardiac resynchronization therapy (CRT) devices. Growth of the Cardiac Monitoring and Cardiac Rhythm Management devices market is propelled by increasing incidences of cardiovascular diseases, technological advancements resulting in launch of products in the mobile cardiac telemetry segment, and emergence of private institutional nursing and home care.
Cardiac surgery devices segment can be categorized into on-pump CABG perfusion circuit devices, off-pump CABG devices, endoscopic vessel harvesting devices, anastomosis-assist devices, heart valves, percutaneous heart valve therapy (PHVT) devices, heart valve repair devices, and ventricular-assist devices. Electrophysiology and Ablation Device segment are categorized into Electrophysiology Diagnostic Catheters, and Electrophysiology Ablation Catheters.
Interventional Cardiology and peripheral vascular devices can be categorized into eight segments: angioplasty stents, catheters, angioplasty balloons, Endovascular Aneurysm Repair (EVAR) Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and accessories. Major factors driving the growth of this market include rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements. Moreover, emerging economies such as India and China present an array of opportunities for the growth of this market.
Marketsandmarkets tracks various cardiology procedures volume such as Percutaneous Transluminal Coronary Angioplasty (PTCA), Percutaneous Transluminal Angioplasty (PTA), Endovascular Aneurysm Repair (EVAR), volume of devices such as Guiding Catheters, Intravascular Ultrasound (IVUS) Catheters/Optical Coherence Tomography (OCT) Catheters, Permanent and Retrievable Inferior Vena Cava (IVC) Filters, Pediatric Interventional Cardiology procedure, measures cost of cardiology procedures and devices used. MarketsandMarkets also tracks number of catheterization laboratories across various geographies. MarketsandMarkets estimates and tracks the value market for each product category of cardiology devices, analyzes recent trends in cardiology device market, technology trends, tracks latest developments such as new product launches, merger and acquisitions, analyzes reimbursement scenario and so on.
see less
-
The global ECG Cable Market boasts a total value of $2.1 billion in 2021 and is projected to register a growth rate of 7.5% to reach a value of $3.0 billion by 2026.The major players Cardinal Health, Inc. (US), 3M Company (US), Becton, Dickinson and Company (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott Laboratories (US), Boston Scientific Corporation (US), CONMED Corporation (US), OSI Systems, Inc. (US), Mindray Medical International Limited (China), Welch Allyn, Inc. (US), Curbell Medical Products, Inc. (US), Schiller AG (US), Siemens Healthineers AG (Germany), Dräger (Germany), Shanghai Berry Electronic Tech Co., Ltd (China), Unimed Medical Supplies Inc. (China), Amydi-med Electronic Technology Co., Ltd. (China), MedLink Electronics Tech Co. Ltd., (China), Sorimex (Poland), Nuova Gmbh (Germany), LUMED (Italy), UpnMed Equipment Co., Ltd.(China), Carlisle Medical Technologies (US), and LifeLine Medical, Inc. (US).
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
The global defibrillator market in terms of revenue was estimated to be worth $11.4 billion in 2021 and is poised to reach $18.2 billion by 2026, growing at a CAGR of 9.7% from 2021 to 2026. The prominent key players in this market are Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan) and MicroPort (China).
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
The diagnostic electrocardiograph (ECG) market is expected to grow from USD 7.5 billion in 2019 to USD 10.3 billion by 2024, at a compound annual growth rate (CAGR) of 6.4% during the forecast period.The major players in the diagnostic ECG market include Koninklijke Philips (Netherlands), GE Healthcare (US), Nihon Kohden (Japan), Asahi Kasei (Japan), and Hill-Rom Holdings (US).
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
The angiography equipment market is projected to reach USD 13.06 Billion by 2023, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
- Published: March 2014
- Price: $ 4950
- TOC Available: